首页分享 De novo biosynthetic pathway and biological functions of bacterial lysophospholipids

De novo biosynthetic pathway and biological functions of bacterial lysophospholipids

来源：花匠小妙招时间：2024-11-13 03:44

[1] TAN ST, RAMESH T, TOH XR, NGUYEN LN. Emerging roles of lysophospholipids in health and disease[J]. Progress in Lipid Research, 2020, 80: 101068 DOI:10.1016/j.plipres.2020.101068. [2] LEE HJ, HONG WG, WOO Y, AHN JH, KO HJ, KIM H, MOON S, HAHN TW, JUNG YM, SONG DK, JUNG YJ. Lysophosphatidylcholine enhances bactericidal activity by promoting phagosome maturation via the activation of the NF-κB pathway during Salmonella infection in mouse macrophages[J]. Molecules and Cells, 2020, 43(12): 989-1001 DOI:10.14348/molcells.2020.0030. [3] YATOMI Y, KURANO M, IKEDA H, IGARASHI K, KANO K, AOKI J. Lysophospholipids in laboratory medicine[J]. Proceedings of the Japan Academy, Series B, 2018, 94(10): 373-389 DOI:10.2183/pjab.94.025. [4] ZOU DY, PEI JW, LAN JF, SANG H, CHEN HJ, YUAN HL, WU D, ZHANG YY, WANG YF, WANG DY, ZOU YJ, CHEN D, REN JN, GAO X, LIN ZY. A SNP of bacterial blc disturbs gut lysophospholipid homeostasis and induces inflammation through epithelial barrier disruption[J]. EBioMedicine, 2020, 52: 102652 DOI:10.1016/j.ebiom.2020.102652. [5] AROURI A, MOURITSEN OG. Membrane-perturbing effect of fatty acids and lysolipids[J]. Progress in Lipid Research, 2013, 52(1): 130-140 DOI:10.1016/j.plipres.2012.09.002. [6] CAO XF, van PUTTEN JPM, WÖSTEN MMSM. Biological functions of bacterial lysophospholipids[M]//Advances in Microbial Physiology. Amsterdam: Elsevier, 2023: 129-154. [7] D'ARRIGO P, SERVI S. Synthesis of lysophospholipids[J]. Molecules, 2010, 15(3): 1354-1377 DOI:10.3390/molecules15031354. [8] FILKIN SY, LIPKIN AV, FEDOROV AN. Phospholipase superfamily: structure, functions, and biotechnological applications[J]. Biochemistry (Moscow), 2020, 85(1): 177-195. [9] LUO Y, HUANG ZH, LIAO JL, LIU ZH, LI XP, YAO S, HE H, HU DJ, REN Z, ZENG HT, YAN QN, ZHAN H. Downregulated GTCPH I/BH4 pathway and decreased function of circulating endothelial progenitor cells and their relationship with endothelial dysfunction in overweight postmenopausal women[J]. Stem Cells International, 2018, 2018: 1-11. [10] DALEBROUX ZD, MATAMOUROS S, WHITTINGTON D, BISHOP RE, MILLER SI. PhoPQ regulates acidic glycerophospholipid content of the Salmonella Typhimurium outer membrane[J]. Proceedings of the National Academy of Sciences of the United States of America, 2014, 111(5): 1963-1968. [11] BISHOP RE, GIBBONS HS, GUINA T, TRENT MS, MILLER SI, RAETZ CR. Transfer of palmitate from phospholipids to lipid A in outer membranes of gram-negative bacteria[J]. The EMBO Journal, 2000, 19(19): 5071-5080 DOI:10.1093/emboj/19.19.5071. [12] HILLMANN F, ARGENTINI M, BUDDELMEIJER N. Kinetics and phospholipid specificity of apolipoprotein N-acyltransferase[J]. The Journal of Biological Chemistry, 2011, 286(32): 27936-27946 DOI:10.1074/jbc.M111.243519. [13] JACKOWSKI S, ROCK CO. Transfer of fatty acids from the 1-position of phosphatidylethanolamine to the major outer membrane lipoprotein of Escherichia coli[J]. Journal of Biological Chemistry, 1986, 261(24): 11328-11333 DOI:10.1016/S0021-9258(18)67387-9. [14] ISTIVAN TS, COLOE PJ. Phospholipase A in Gram-negative bacteria and its role in pathogenesis[J]. Microbiology, 2006, 152(5): 1263-1274 DOI:10.1099/mic.0.28609-0. [15] SCHMIEL DH, MILLER VL. Bacterial phospholipases and pathogenesis[J]. Microbes and Infection, 1999, 1(13): 1103-1112 DOI:10.1016/S1286-4579(99)00205-1. [16] GAIRE BP, CHOI JW. Critical roles of lysophospholipid receptors in activation of neuroglia and their neuroinflammatory responses[J]. International Journal of Molecular Sciences, 2021, 22(15): 7864 DOI:10.3390/ijms22157864. [17] GRÄLER M. Lysophospholipids and their G protein-coupled receptors in inflammation and immunity[J]. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 2002, 1582(1/2/3): 168-174. [18] PAKIET A, SIKORA K, KOBIELA J, ROSTKOWSKA O, MIKA A, SLEDZINSKI T. Alterations in complex lipids in tumor tissue of patients with colorectal cancer[J]. Lipids in Health and Disease, 2021, 20(1): 1-11 DOI:10.1186/s12944-020-01429-x. [19] DROBNIK W, LIEBISCH G, AUDEBERT FX, FRÖHLICH D, GLÜCK T, VOGEL P, ROTHE G, SCHMITZ G. Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients[J]. Journal of Lipid Research, 2003, 44(4): 754-761 DOI:10.1194/jlr.M200401-JLR200. [20] KURANO M, DOHI T, NOJIRI T, KOBAYASHI T, HIROWATARI Y, INOUE A, KANO K, MATSUMOTO H, IGARASHI K, NISHIKAWA M, MIYAUCHI K, DAIDA H, IKEDA H, AOKI J, YATOMI Y. Blood levels of serotonin are specifically correlated with plasma lysophosphatidylserine among the glycero-lysophospholipids[J]. BBA Clinical, 2015, 4: 92-98 DOI:10.1016/j.bbacli.2015.08.003. [21] TAYLOR LA, ARENDS J, HODINA AK, UNGER C, MASSING U. Plasma lyso-phosphatidylcholine concentration is decreased in cancer patients with weight loss and activated inflammatory status[J]. Lipids in Health and Disease, 2007, 6: 17 DOI:10.1186/1476-511X-6-17. [22] AOKI J. Structure and function of phosphatidylserine-specific phospholipase A1[J]. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 2002, 1582(1/2/3): 26-32. [23] KURANO M, KANO K, HARA M, TSUKAMOTO K, AOKI J, YATOMI Y. Regulation of plasma glycero-lysophospholipid levels by lipoprotein metabolism[J]. Biochemical Journal, 2019, 476(23): 3565-3581 DOI:10.1042/BCJ20190498. [24] MISRA UK. Isolation of lysophosphatidylethanolamine from human serum[J]. Biochimica et Biophysica Acta (BBA)-Lipids and Lipid Metabolism, 1965, 106(2): 371-378 DOI:10.1016/0005-2760(65)90045-7. [25] MORENO-NAVARRETE JM, CATALÁN V, WHYTE L, DÍAZ-ARTEAGA A, VÁZQUEZ-MARTÍNEZ R, ROTELLAR F, GUZMÁN R, GÓMEZ-AMBROSI J, PULIDO MR, RUSSELL WR, IMBERNÓN M, ROSS RA, MALAGÓN MM, DIEGUEZ C, FERNÁNDEZ- REAL JM, FRÜHBECK G, NOGUEIRAS R. The l-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity[J]. Diabetes, 2012, 61(2): 281-291 DOI:10.2337/db11-0649. [26] QUEHENBERGER O, ARMANDO AM, BROWN AH, MILNE SB, MYERS DS, MERRILL AH, BANDYOPADHYAY S, JONES KN, KELLY S, SHANER RL, SULLARDS CM, WANG E, MURPHY RC, BARKLEY RM, LEIKER TJ, RAETZ CRH, GUAN ZQ, LAIRD GM, SIX DA, RUSSELL DW, et al. Lipidomics reveals a remarkable diversity of lipids in human plasma[J]. Journal of Lipid Research, 2010, 51(11): 3299-3305 DOI:10.1194/jlr.M009449. [27] SALOUS AK, PANCHATCHARAM M, SUNKARA M, MUELLER P, DONG AP, WANG YH, GRAF GA, SMYTH SS, MORRIS AJ. Mechanism of rapid elimination of lysophosphatidic acid and related lipids from the circulation of mice[J]. Journal of Lipid Research, 2013, 54(10): 2775-2784 DOI:10.1194/jlr.M039685. [28] LIN Y, BOGDANOV M, LU S, GUAN Z, MARGOLIN W, WEISS J, ZHENG L. The phospholipid-repair system LplT/Aas in Gram-negative bacteria protects the bacterial membrane envelope from host phospholipase A2 attack[J]. Journal of Biological Chemistry, 2018, 293(9): 3386-3398 DOI:10.1074/jbc.RA117.001231. [29] RAMRAKHIANI L, CHAND S. Recent progress on phospholipases: different sources, assay methods, industrial potential and pathogenicity[J]. Applied Biochemistry and Biotechnology, 2011, 164(7): 991-1022 DOI:10.1007/s12010-011-9190-6. [30] SUTPHEN R, XU Y, WILBANKS GD, FIORICA J, GRENDYS EC Jr, LaPOLLA JP, ARANGO H, HOFFMAN MS, MARTINO M, WAKELEY K, GRIFFIN D, BLANCO RW, CANTOR AB, XIAO YJ, KRISCHER JP. Lysophospholipids are potential biomarkers of ovarian cancer[J]. Cancer Epidemiology, Biomarkers & Prevention: a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2004, 13(7): 1185-1191. [31] HØYRUP P, DAVIDSEN J, JØRGENSEN K. Lipid membrane partitioning of lysolipids and fatty acids: effects of membrane phase structure and detergent chain length[J]. The Journal of Physical Chemistry B, 2001, 105(13): 2649-2657 DOI:10.1021/jp003631o. [32] MOURITSEN OG. Lipids, curvature, and nano-medicine[J]. European Journal of Lipid Science and Technology: EJLST, 2011, 113(10): 1174-1187 DOI:10.1002/ejlt.201100050. [33] WRIGHT GC, WEISS J, KIM KS, VERHEIJ H, ELSBACH P. Bacterial phospholipid hydrolysis enhances the destruction of Escherichia coli ingested by rabbit neutrophils. Role of cellular and extracellular phospholipases[J]. Journal of Clinical Investigation, 1990, 85(6): 1925-1935 DOI:10.1172/JCI114655. [34] DUAN L, GAN HX, ARM J, REMOLD HG. Cytosolic phospholipase A2 participates with TNF-α in the induction of apoptosis of human macrophages infected with Mycobacterium tuberculosis H37Ra[J]. The Journal of Immunology, 2001, 166(12): 7469-7476 DOI:10.4049/jimmunol.166.12.7469. [35] RAJARAM MVS, BROOKS MN, MORRIS JD, TORRELLES JB, AZAD AK, SCHLESINGER LS. Mycobacterium tuberculosis activates human macrophage peroxisome proliferator-activated receptor gamma linking mannose receptor recognition to regulation of immune responses[J]. Journal of Immunology (Baltimore, Md: 1950), 2010, 185(2): 929-942 DOI:10.4049/jimmunol.1000866. [36] SUBRAMANIAN N, QADRI A. Lysophospholipid sensing triggers secretion of flagellin from pathogenic salmonella[J]. Nature Immunology, 2006, 7(6): 583-589 DOI:10.1038/ni1336. [37] ZHENG L, LIN YB, LU S, ZHANG JZ, BOGDANOV M. Biogenesis, transport and remodeling of lysophospholipids in Gram-negative bacteria[J]. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 2017, 1862(11): 1404-1413. [38] DAVIDSEN J, MOURITSEN OG, JØRGENSEN K. Synergistic permeability enhancing effect of lysophospholipids and fatty acids on lipid membranes[J]. Biochimica et Biophysica Acta (BBA)- Biomembranes, 2002, 1564(1): 256-262 DOI:10.1016/S0005-2736(02)00461-3. [39] LIN SB, HAN YR, JENKIN K, LEE SJ, SASAKI M, KLAPPROTH JM, HE PJ, YUN CC. Lysophosphatidic acid receptor 1 is important for intestinal epithelial barrier function and susceptibility to colitis[J]. The American Journal of Pathology, 2018, 188(2): 353-366 DOI:10.1016/j.ajpath.2017.10.006. [40] FOREMAN-WYKERT AK, WEISS J, ELSBACH P. Phospholipid synthesis by Staphylococcus aureus during (Sub) lethal attack by mammalian 14-kilodalton group IIA phospholipase A2[J]. Infection and Immunity, 2000, 68(3): 1259-1264 DOI:10.1128/IAI.68.3.1259-1264.2000. [41] KONDO E, KANAI K. Mechanism of bactericidal activity of lysolecithin and its biological implication[J]. Japanese Journal of Medical Science and Biology, 1985, 38(4): 181-194 DOI:10.7883/yoken1952.38.181. [42] CAO XF, BROUWERS JFHM, van DIJK L, van de LEST CHA, PARKER CT, HUYNH S, van PUTTEN JPM, KELLY DJ, WÖSTEN MMSM. The unique phospholipidome of the enteric pathogen Campylobacter jejuni: lysophosholipids are required for motility at low oxygen availability[J]. Journal of Molecular Biology, 2020, 432(19): 5244-5258 DOI:10.1016/j.jmb.2020.07.012. [43] GILES DK, HANKINS JV, GUAN ZQ, STEPHEN TRENT M. Remodelling of the Vibrio cholerae membrane by incorporation of exogenous fatty acids from host and aquatic environments[J]. Molecular Microbiology, 2011, 79(3): 716-728 DOI:10.1111/j.1365-2958.2010.07476.x. [44] LÓPEZ-LARA IM, GEIGER O. Bacterial lipid diversity[J]. Biochimica et Biophysica Acta Molecular and Cell Biology of Lipids, 2017, 1862(11): 1287-1299 DOI:10.1016/j.bbalip.2016.10.007. [45] BUKHOLM G, TANNÆS T, NEDENSKOV P, ESBENSEN Y, GRAV HJ, HOVIG T, ARIANSEN S, GULDVOG I. Colony variation of Helicobacter pylori: pathogenic potential is correlated to cell wall lipid composition[J]. Scandinavian Journal of Gastroenterology, 1997, 32(5): 445-454 DOI:10.3109/00365529709025079. [46] DAVYDOVA L, BAKHOLDINA S, BARKINA M, VELANSKY P, BOGDANOV M, SANINA N. Effects of elevated growth temperature and heat shock on the lipid composition of the inner and outer membranes of Yersinia pseudotuberculosis[J]. Biochimie, 2016, 123: 103-109 DOI:10.1016/j.biochi.2016.02.004. [47] KERN R, JOSELEAU-PETIT D, CHATTOPADHYAY MK, RICHARME G. Chaperone-like properties of lysophospholipids[J]. Biochemical and Biophysical Research Communications, 2001, 289(5): 1268-1274 DOI:10.1006/bbrc.2001.6093. [48] TANNÆS T, DEKKER N, BUKHOLM G, BIJLSMA JJE, APPELMELK BJ. Phase variation in the Helicobacter pylori phospholipase A gene and its role in acid adaptation[J]. Infection and Immunity, 2001, 69(12): 7334-7340 DOI:10.1128/IAI.69.12.7334-7340.2001. [49] CAO XF, van de LEST CHA, HUANG LZX, van PUTTEN JPM, WÖSTEN MMSM. Campylobacter jejuni permeabilizes the host cell membrane by short chain lysophosphatidylethanolamines[J]. Gut Microbes, 2022, 14(1): 2091371 DOI:10.1080/19490976.2022.2091371. [50] COLLES SM, CHISOLM GM. Lysophosphatidylcholine- induced cellular injury in cultured fibroblasts involves oxidative events[J]. Journal of Lipid Research, 2000, 41(8): 1188-1198 DOI:10.1016/S0022-2275(20)33425-8. [51] BEN-ZEEV G, TELIAS M, NUSSINOVITCH I. Lysophospholipids modulate voltage-gated calcium channel currents in pituitary cells; effects of lipid stress[J]. Cell Calcium, 2010, 47(6): 514-524 DOI:10.1016/j.ceca.2010.04.006. [52] BAVI O, VOSSOUGHI M, NAGHDABADI R, JAMALI Y. The effect of local bending on gating of MscL using a representative volume element and finite element simulation[J]. Channels, 2014, 8(4): 344-349 DOI:10.4161/chan.29572. [53] VÁSQUEZ V, SOTOMAYOR M, CORDERO- MORALES J, SCHULTEN K, PEROZO E. A structural mechanism for MscS gating in lipid bilayers[J]. Science, 2008, 321(5893): 1210-1214 DOI:10.1126/science.1159674. [54] SNIJDER HJ, UBARRETXENA-BELANDIA I, BLAAUW M, KALK KH, VERHEIJ HM, EGMOND MR, DEKKER N, DIJKSTRA BW. Structural evidence for dimerization-regulated activation of an integral membrane phospholipase[J]. Nature, 1999, 401(6754): 717-721 DOI:10.1038/401717a0. [55] DEKKER N, TOMMASSEN J, LUSTIG A, ROSENBUSCH JP, VERHEIJ HM. Dimerization regulates the enzymatic activity of Escherichia coli outer membrane phospholipase A[J]. Journal of Biological Chemistry, 1997, 272(6): 3179-3184 DOI:10.1074/jbc.272.6.3179. [56] BALAZS L, OKOLICANY J, FERREBEE M, TOLLEY B, TIGYI G. Topical application of the phospholipid growth factor lysophosphatidic acid promotes wound healing in vivo[J]. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2001, 280(2): R466-R472 DOI:10.1152/ajpregu.2001.280.2.R466. [57] GUEGUEN G, GAIGÉ B, GRÉVY JM, ROGALLE P, BELLAN J, WILSON M, KLAÉBÉ A, PONT F, SIMON MF, CHAP H. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation[J]. Biochemistry, 1999, 38(26): 8440-8450 DOI:10.1021/bi9816756. [58] 杨晋静, 陈海波, 王宪云, 范雪松, 丛祥凤, 陈曦. 溶血磷脂酸对心肌细胞缺氧/复氧损伤的保护作用及机制[J]. 中国循环杂志, 2013, 28(3): 222-225. DOI:10.3969/j.issn.1000-3614.2013.03.018
YANG JJ, CHEN HB, WANG XY, FAN XS, CONG XF, CHEN X. The protective role with its mechanism of lysophosphatidic acid on hypoxia/re-oxygenation induced neonatal rat's H9c2 cardiomyocyte injury[J]. Chinese Circulation Journal, 2013, 28(3): 222-225 (in Chinese). [59] ZHANG YM, ROCK CO. Membrane lipid homeostasis in bacteria[J]. Nature Reviews Microbiology, 2008, 6(3): 222-233 DOI:10.1038/nrmicro1839. [60] MATHEW D, TORRES RM. Lysophosphatidic acid is an inflammatory lipid exploited by cancers for immune evasion via mechanisms similar and distinct from CTLA-4 and PD-1[J]. Frontiers in Immunology, 2021, 11: 531910 DOI:10.3389/fimmu.2020.531910. [61] SOHLENKAMP C, GEIGER O. Bacterial membrane lipids: diversity in structures and pathways[J]. FEMS Microbiology Reviews, 2016, 40(1): 133-159 DOI:10.1093/femsre/fuv008. [62] LIN Y, BOGDANOV M, TONG S, GUAN Z, ZHENG L. Substrate selectivity of lysophospholipid transporter LplT involved in membrane phospholipid remodeling in Escherichia coli[J]. Journal of Biological Chemistry, 2016, 291(5): 2136-2149 DOI:10.1074/jbc.M115.700419. [63] KIM H, KIM M, MYOUNG K, KIM W, KO J, KIM KP, CHO EG. Comparative lipidomic analysis of extracellular vesicles derived from Lactobacillus plantarum APsulloc 331261 living in green tea leaves using liquid chromatography-mass spectrometry[J]. International Journal of Molecular Sciences, 2020, 21(21): 8076 DOI:10.3390/ijms21218076. [64] LIN SB, YERUVA S, HE PJ, SINGH AK, ZHANG HC, CHEN MM, LAMPRECHT G, de JONGE HR, TSE M, DONOWITZ M, HOGEMA BM, CHUN J, SEIDLER U, YUN CC. Lysophosphatidic acid stimulates the intestinal brush border Na(+)/H(+) exchanger 3 and fluid absorption via LPA(5) and NHERF2[J]. Gastroenterology, 2010, 138(2): 649-658 DOI:10.1053/j.gastro.2009.09.055. [65] URANBILEG B, ITO N, KURANO M, SAIGUSA D, SAITO R, URUNO A, KANO K, IKEDA H, YAMADA Y, SUMITANI M, SEKIGUCHI M, AOKI J, YATOMI Y. Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: a study using a rat cauda equina compression model[J]. Scientific Reports, 2019, 9: 16578 DOI:10.1038/s41598-019-52999-5. [66] HERR DR, ONG JHJ, ONG WY. Potential therapeutic applications for inhibitors of autotaxin, a bioactive lipid-producing lysophospholipase D, in disorders affecting the nervous system[J]. ACS Chemical Neuroscience, 2018, 9(3): 398-400 DOI:10.1021/acschemneuro.8b00057. [67] KAO CY, KUO PY, LIAO HW. Untargeted microbial exometabolomics and metabolomics analysis of Helicobacter pylori J99 and jhp0106 mutant[J]. Metabolites, 2021, 11(12): 808 DOI:10.3390/metabo11120808. [68] YANG J, WEI H, ZHOU YF, SZETO CH, LI CG, LIN YF, COKER OO, LAU HCH, CHAN AWH, SUNG JJY, YU J. High-fat diet promotes colorectal tumorigenesis through modulating gut microbiota and metabolites[J]. Gastroenterology, 2022, 162(1): 135-149.e2 DOI:10.1053/j.gastro.2021.08.041. [69] GENG T, SU S, SUN K, ZHAO L, ZHAO Y, BAO N, PAN L, SUN H. Effects of feeding a Lactobacillus plantarum JL01 diet on caecal bacteria and metabolites of weaned piglets[J]. Letters in Applied Microbiology, 2021, 72(1): 24-35 DOI:10.1111/lam.13399. [70] HOQUE KM, CHAKRABORTY S, ALI SHEIKH I, WOODWARD OM. New advances in the pathophysiology of intestinal ion transport and barrier function in diarrhea and the impact on therapy[J]. Expert Review of Anti-Infective Therapy, 2012, 10(6): 687-699 DOI:10.1586/eri.12.47. [71] LIN ME, HERR DR, CHUN J. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance[J]. Prostaglandins & Other Lipid Mediators, 2010, 91(3/4): 130-138. [72] DAS S, JAYARATNE R, BARRETT KE. The role of ion transporters in the pathophysiology of infectious diarrhea[J]. Cellular and Molecular Gastroenterology and Hepatology, 2018, 6(1): 33-45 DOI:10.1016/j.jcmgh.2018.02.009. [73] LI CY, DANDRIDGE KS, DI AK, MARRS KL, HARRIS EL, ROY K, JACKSON JS, MAKAROVA NV, FUJIWARA Y, FARRAR PL, NELSON DJ, TIGYI GJ, NAREN AP. Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions[J]. The Journal of Experimental Medicine, 2005, 202(7): 975-986 DOI:10.1084/jem.20050421. [74] SINGLA A, DWIVEDI A, SAKSENA S, GILL RK, ALREFAI WA, RAMASWAMY K, DUDEJA PK. Mechanisms of lysophosphatidic acid (LPA) mediated stimulation of intestinal apical Cl–/OH– exchange[J]. American Journal of Physiology Gastrointestinal and Liver Physiology, 2010, 298(2): G182-G189 DOI:10.1152/ajpgi.00345.2009. [75] 陈荷丹, 林晓庆, 薛纪极, 朱坚胜. 溶血磷脂酸受体1与器官纤维化关系的研究进展[J]. 浙江医学, 2022, 44(12): 1337-1341. DOI:10.12056/j.issn.1006-2785.2022.44.12.2021-2640
CHEN HD, LIN XQ, XUE JJ, ZHU JS. Research progress on the relationship between lysophosphatidic acid receptor 1 and organ fibrosis[J]. Zhejiang Medical Journal, 2022, 44(12): 1337-1341 (in Chinese). [76] EMO J, MEEDNU N, CHAPMAN TJ, REZAEE F, BALYS M, RANDALL T, RANGASAMY T, GEORAS SN. Lpa2 is a negative regulator of both dendritic cell activation and murine models of allergic lung inflammation[J]. Journal of Immunology (Baltimore, Md: 1950), 2012, 188(8): 3784-3790 DOI:10.4049/jimmunol.1102956. [77] OCHI S, ODA M, NAGAHAMA M, SAKURAI J. Clostridium perfringens alpha-toxin-induced hemolysis of horse erythrocytes is dependent on Ca2+ uptake[J]. Biochimica et Biophysica Acta (BBA)-Biomembranes, 2003, 1613(1/2): 79-86. [78] SAKURAI J, OCHI S, TANAKA H. Evidence for coupling of Clostridium perfringens alpha-toxin-induced hemolysis to stimulated phosphatidic acid formation in rabbit erythrocytes[J]. Infection and Immunity, 1993, 61(9): 3711-3718 DOI:10.1128/iai.61.9.3711-3718.1993. [79] WANG J, HERTZ L, RUPPENTHAL S, EL NEMER W, CONNES P, GOEDE JS, BOGDANOVA A, BIRNBAUMER L, KAESTNER L. Lysophosphatidic acid-activated calcium signaling is elevated in red cells from sickle cell disease patients[J]. Cells, 2021, 10(2): 456 DOI:10.3390/cells10020456. [80] 韩黎, 吴旭琴, 孟玉芬, 纪蕾, 陈世平. 李斯特菌诱导宿主细胞骨架重排与磷脂酶D[J]. 微生物学报, 2006, 46(5): 852-855. DOI:10.3321/j.issn:0001-6209.2006.05.036
HAN L, WU XQ, MENG YF, JI L, CHEN SP. Listeria-induced host cellular actin cytoskeleton rearrangement and phospholipase D[J]. Acta Microbiologica Sinica, 2006, 46(5): 852-855 (in Chinese). [81] BOLDYREVA LV, MOROZOVA MV, SAYDAKOVA SS, KOZHEVNIKOVA EN. Fat of the gut: epithelial phospholipids in inflammatory bowel diseases[J]. International Journal of Molecular Sciences, 2021, 22(21): 11682 DOI:10.3390/ijms222111682. [82] MAKIDE K, KITAMURA H, SATO Y, OKUTANI M, AOKI J. Emerging lysophospholipid mediators, lysophosphatidylserine, lysophosphatidylthreonine, lysophosphatidylethanolamine and lysophosphatidylglycerol[J]. Prostaglandins & Other Lipid Mediators, 2009, 89(3/4): 135-139. [83] HUI DY. Intestinal phospholipid and lysophospholipid metabolism in cardiometabolic disease[J]. Current Opinion in Lipidology, 2016, 27(5): 507-512 DOI:10.1097/MOL.0000000000000334. [84] KNUPLEZ E, MARSCHE G. An updated review of pro- and anti-inflammatory properties of plasma lysophosphatidylcholines in the vascular system[J]. International Journal of Molecular Sciences, 2020, 21(12): 4501 DOI:10.3390/ijms21124501. [85] ROKITSKAYA TI, KOTOVA EA, NABEREZHNYKH GA, KHOMENKO VA, GORBACH VI, FIRSOV AM, ZELEPUGA EA, ANTONENKO YN, NOVIKOVA OD. Single channel activity of OmpF-like porin from Yersinia pseudotuberculosis[J]. Biochimica et Biophysica Acta (BBA)-Biomembranes, 2016, 1858(4): 883-891 DOI:10.1016/j.bbamem.2016.02.005. [86] PEROZO E, CORTES DM, SOMPORNPISUT P, KLODA A, MARTINAC B. Open channel structure of MscL and the gating mechanism of mechanosensitive channels[J]. Nature, 2002, 418(6901): 942-948 DOI:10.1038/nature00992. [87] VAARA M, PORRO M. Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria[J]. Antimicrobial Agents and Chemotherapy, 1996, 40(8): 1801-1805 DOI:10.1128/AAC.40.8.1801. [88] MIYAZAKI H, MIDORIKAWA N, FUJIMOTO S, MIYOSHI N, YOSHIDA H, MATSUMOTO T. Antimicrobial effects of lysophosphatidylcholine on methicillin-resistant Staphylococcus aureus[J]. Therapeutic Advances in Infectious Disease, 2017, 4(4): 89-94 DOI:10.1177/2049936117714920. [89] STEEL HC, COCKERAN R, ANDERSON R. Platelet-activating factor and lyso-PAF possess direct antimicrobial properties in vitro[J]. APMIS, 2002, 110(2): 158-164 DOI:10.1034/j.1600-0463.2002.100206.x. [90] YADAV J, ISMAEEL S, QADRI A. Lysophosphatidylcholine potentiates antibacterial activity of polymyxin B[J]. Antimicrobial Agents and Chemotherapy, 2020, 64(12): e01337-e01320. [91] YAN JJ, JUNG JS, LEE JE, LEE J, HUH SO, KIM HS, JUNG KC, CHO JY, NAM JS, SUH HW, KIM YH, SONG DK. Therapeutic effects of lysophosphatidylcholine in experimental sepsis[J]. Nature Medicine, 2004, 10(2): 161-167 DOI:10.1038/nm989. [92] SHIVCHARAN S, YADAV J, QADRI A. Host lipid sensing promotes invasion of cells with pathogenic Salmonella[J]. Scientific Reports, 2018, 8: 15501 DOI:10.1038/s41598-018-33319-9. [93] LOU LX, ZHANG P, PIAO RL, WANG Y. Salmonella pathogenicity island 1 (SPI-1) and its complex regulatory network[J]. Frontiers in Cellular and Infection Microbiology, 2019, 9: 270 DOI:10.3389/fcimb.2019.00270. [94] JURKOWITZ MS, AZAD AK, MONSMA PC, KEISER TL, KANYO J, LAM TT, BELL CE, SCHLESINGER LS. Mycobacterium tuberculosis encodes a YhhN family membrane protein with lysoplasmalogenase activity that protects against toxic host lysolipids[J]. The Journal of Biological Chemistry, 2022, 298(5): 101849 DOI:10.1016/j.jbc.2022.101849. [95] TANG XL, WANG WJ, HONG GC, DUAN CH, ZHU SR, TIAN YE, HAN CQ, QIAN W, LIN R, HOU XH. Gut microbiota-mediated lysophosphatidylcholine generation promotes colitis in intestinal epithelium-specific Fut2 deficiency[J]. Journal of Biomedical Science, 2021, 28(1): 20 DOI:10.1186/s12929-021-00711-z. [96] AILTE I, LINGELEM ABD, KAVALIAUSKIENE S, BERGAN J, KVALVAAG AS, MYRANN AG, SKOTLAND T, SANDVIG K. Addition of lysophospholipids with large head groups to cells inhibits Shiga toxin binding[J]. Scientific Reports, 2016, 6: 30336 DOI:10.1038/srep30336. [97] OLIVER JD, COLWELL RR. Extractable lipids of gram-negative marine bacteria: phospholipid composition[J]. Journal of Bacteriology, 1973, 114(3): 897-908 DOI:10.1128/jb.114.3.897-908.1973. [98] CESARI AB, PAULUCCI NS, BIASUTTI MA, MORALES GM, DARDANELLI MS. Changes in the lipid composition of Bradyrhizobium cell envelope reveal a rapid response to water deficit involving lysophosphatidylethanolamine synthesis from phosphatidylethanolamine in outer membrane[J]. Research in Microbiology, 2018, 169(6): 303-312 DOI:10.1016/j.resmic.2018.05.008. [99] QIU N, MISRA R. Overcoming iron deficiency of an Escherichia coli tonB mutant by increasing outer membrane permeability[J]. Journal of Bacteriology, 2019, 201(17): e00340. [100] FULLER N, RAND RP. The influence of lysolipids on the spontaneous curvature and bending elasticity of phospholipid membranes[J]. Biophysical Journal, 2001, 81(1): 243-254 DOI:10.1016/S0006-3495(01)75695-0. [101] NINA S, LUDMILA D, SVETLANA B, OLGA N, OLGA P, TAMARA S, VALERY S, MIKHAIL B. Effect of phenol-induced changes in lipid composition on conformation of OmpF-like porin of Yersinia pseudotuberculosis[J]. FEBS Letters, 2013, 587(14): 2260-2265 DOI:10.1016/j.febslet.2013.05.056. [102] SANINA N, POMAZENKOVA L, BAKHOLDINA S, CHOPENKO N, ZABOLOTNAYA A, REUTOV V, STENKOVA A, BYSTRITSKAYA E, BOGDANOV M. Relationship between adaptive changing of lysophosphatidylethanolamine content in the bacterial envelope and ampicillin sensitivity of Yersinia pseudotuberculosis[J]. Microbial Physiology, 2019, 28(5): 236-239. [103] BAKHOLDINA SI, SANINA NM, SHUBIN FN, POPOVA OB, SOLOV'EVA TF. Thermotropic behavior of lipids and the morphology of Yersinia pseudotuberculosis cells with a high content of lysophosphatidylethanolamine[J]. Microbiology, 2007, 76(3): 280-286 DOI:10.1134/S0026261707030046. [104] TANNAES T, BUKHOLM IK, BUKHOLM G. High relative content of lysophospholipids of Helicobacter pylori mediates increased risk for ulcer disease[J]. FEMS Immunology and Medical Microbiology, 2005, 44(1): 17-23 DOI:10.1016/j.femsim.2004.10.003. [105] CRONAN JE JR, WULFF DL. A role for phospholipid hydrolysis in the lysis of Escherichia coli infected with bacteriophage T4[J]. Virology, 1969, 38(2): 241-246 DOI:10.1016/0042-6822(69)90365-1. [106] PUGSLEY AP, SCHWARTZ M. Colicin E2 release: lysis, leakage or secretion? Possible role of a phospholipase[J]. The EMBO Journal, 1984, 3(10): 2393-2397 DOI:10.1002/j.1460-2075.1984.tb02145.x. [107] HARDAWAY KL, BULLER CS. Effect of ethylenediaminetetraacetate on phospholipids and outer membrane function in Escherichia coli[J]. Journal of Bacteriology, 1979, 137(1): 62-68 DOI:10.1128/jb.137.1.62-68.1979. [108] MICHEL GPF, STARKA J. Origin and fate of the lysophosphatidylethanolamine in a chain-forming mutant (envC) of Escherichia coli[J]. Microbiology, 1984, 130(6): 1391-1398 DOI:10.1099/00221287-130-6-1391. [109] CAO XF, BROUWERS JFHM, van DIJK L, van de LEST CHA, PARKER CT, HUYNH S, van PUTTEN JPH, KELLY DJ, WÖSTEN MMSM. Dataset of the phospholipidome and transcriptome of Campylobacter jejuni under different growth conditions[J]. Data in Brief, 2020, 33: 106349 DOI:10.1016/j.dib.2020.106349. [110] VANHOVE AS, HANG SY, VIJAYAKUMAR V, WONG AC, ASARA JM, WATNICK PI. Vibrio cholerae ensures function of host proteins required for virulence through consumption of luminal methionine sulfoxide[J]. PLoS Pathogens, 2017, 13(6): e1006428 DOI:10.1371/journal.ppat.1006428. [111] LIN AS, SHUMAN JHB, KOTNALA A, SHAW JA, BECKETT AC, HARVEY JL, TUCK M, DIXON BREA, REYZER ML, ALGOOD HMS, SCHEY KL, PIAZUELO MB, COVER TL. Loss of corpus-specific lipids in Helicobacter pylori-induced atrophic gastritis[J]. mSphere, 2021, 6(6): e00826. [112] LI RS. Lysophospholipids and their G protein-coupled receptors in atherosclerosis[J]. Frontiers in Bioscience, 2016, 21(1): 70-88 DOI:10.2741/4377. [113] LIU YY, ZHU Y, WICKREMASINGHE H, BERGEN PJ, LU J, ZHU XQ, ZHOU QL, AZAD M, NANG SC, HAN ML, LEI T, LI J, LIU JH. Metabolic perturbations caused by the over-expression of mcr-1 in Escherichia coli[J]. Frontiers in Microbiology, 2020, 11: 588658 DOI:10.3389/fmicb.2020.588658. [114] KANJEE U, HOURY WA. Mechanisms of acid resistance in Escherichia coli[J]. Annual Review of Microbiology, 2013, 67: 65-81 DOI:10.1146/annurev-micro-092412-155708. [115] FOSTER JW. Escherichia coli acid resistance: tales of an amateur acidophile[J]. Nature Reviews Microbiology, 2004, 2(11): 898-907 DOI:10.1038/nrmicro1021. [116] POROCA DR, PELIS RM, CHAPPE VM. ClC channels and transporters: structure, physiological functions, and implications in human chloride channelopathies[J]. Frontiers in Pharmacology, 2017, 8: 151. [117] LUND P, TRAMONTI A, de BIASE D. Coping with low pH: molecular strategies in neutralophilic bacteria[J]. FEMS Microbiology Reviews, 2014, 38(6): 1091-1125 DOI:10.1111/1574-6976.12076. [118] GHAI I, GHAI S. Exploring bacterial outer membrane barrier to combat bad bugs[J]. Infection and Drug Resistance, 2017, 10: 261-273 DOI:10.2147/IDR.S144299. [119] ANDERSEN OS, KOEPPE RE II. Bilayer thickness and membrane protein function: an energetic perspective[J]. Annual Review of Biophysics and Biomolecular Structure, 2007, 36: 107-130 DOI:10.1146/annurev.biophys.36.040306.132643. [120] LUNDBÆK JA, BIRN P, GIRSHMAN J, HANSEN AJ, ANDERSEN OS. Membrane stiffness and channel function[J]. Biochemistry, 1996, 35(12): 3825-3830 DOI:10.1021/bi952250b. [121] LI BY, YIN F, ZHAO XY, GUO YX, WANG WQ, WANG PX, ZHU HH, YIN YS, WANG XX. Colistin resistance gene mcr-1 mediates cell permeability and resistance to hydrophobic antibiotics[J]. Frontiers in Microbiology, 2020, 10: 3015 DOI:10.3389/fmicb.2019.03015. [122] YANG QE, LI M, SPILLER OB, ANDREY DO, HINCHLIFFE P, LI H, MACLEAN C, NIUMSUP P, POWELL L, PRITCHARD M, PAPKOU A, SHEN YB, PORTAL E, SANDS K, SPENCER J, TANSAWAI U, THOMAS D, WANG SL, WANG Y, SHEN JZ, et al. Balancing mcr-1 expression and bacterial survival is a delicate equilibrium between essential cellular defence mechanisms[J]. Nature Communications, 2017, 8: 2054 DOI:10.1038/s41467-017-02149-0. [123] MEYLAERS K, CLYNEN E, DALOZE D, DELOOF A, SCHOOFS L. Identification of 1-lysophosphatidylethanolamine (C16: 1) as an antimicrobial compound in the housefly, Musca domestica[J]. Insect Biochemistry and Molecular Biology, 2004, 34(1): 43-49 DOI:10.1016/j.ibmb.2003.09.001. [124] BILL MK, BRINKMANN S, OBERPAUL M, PATRAS MA, LEIS B, MARNER M, MAITRE MP, HAMMANN PE, VILCINSKAS A, SCHULER SMM, SCHÄBERLE TF. Novel glycerophospholipid, lipo- and N-acyl amino acids from bacteroidetes: isolation, structure elucidation and bioactivity[J]. Molecules, 2021, 26(17): 5195 DOI:10.3390/molecules26175195. [125] GRÜNDLING A. Potassium uptake systems in Staphylococcus aureus: new stories about ancient systems[J]. mBio, 2013, 4(5): e00784. [126] KAWANO M, ABUKI R, IGARASHI K, KAKINUMA Y. Potassium uptake with low affinity and high rate in Enterococcus hirae at alkaline pH[J]. Archives of Microbiology, 2001, 175(1): 41-45 DOI:10.1007/s002030000234. [127] KAKINUMA Y, YASUMURA K, IGARASHI K. Potassium/proton antiport system is dispensable for growth of Enterococcus hirae at low pH[J]. Bioscience, Biotechnology, and Biochemistry, 1999, 63(5): 875-878 DOI:10.1271/bbb.63.875. [128] WOZNICA A, CANTLEY AM, BEEMELMANNS C, FREINKMAN E, CLARDY J, KING N. Bacterial lipids activate, synergize, and inhibit a developmental switch in choanoflagellates[J]. Proceedings of the National Academy of Sciences of the United States of America, 2016, 113(28): 7894-7899. [129] GUO HJ, RISCHER M, WESTERMANN M, BEEMELMANNS C. Two distinct bacterial biofilm components trigger metamorphosis in the colonial hydrozoan Hydractinia echinata[J]. mBio, 2021, 12(3): e00401. [130] SUZUKI T. Regulation of intestinal epithelial permeability by tight junctions[J]. Cellular and Molecular Life Sciences, 2013, 70(4): 631-659 DOI:10.1007/s00018-012-1070-x. [131] ZHU WH, HAMMAD LA, HSU F, MAO YX, LUO ZQ. Induction of caspase 3 activation by multiple Legionella pneumophila Dot/icm substrates[J]. Cellular Microbiology, 2013, 15(11): 1783-1795. [132] BALDA MS, GONZALEZ-MARISCAL L, MATTER K, CEREIJIDO M, ANDERSON JM. Assembly of the tight junction: the role of diacylglycerol[J]. Journal of Cell Biology, 1993, 123(2): 293-302 DOI:10.1083/jcb.123.2.293. [133] RHIM JH, JANG IS, YEO EJ, SONG KY, PARK SC. Role of protein kinase C-dependent A-kinase anchoring proteins in lysophosphatidic acid-induced cAMP signaling in human diploid fibroblasts[J]. Aging Cell, 2006, 5(6): 451-461 DOI:10.1111/j.1474-9726.2006.00239.x. [134] HITE RD, SEEDS MC, SAFTA AM, JACINTO RB, GYVES JI, BASS DA, WAITE BM. Lysophospholipid generation and phosphatidylglycerol depletion in phospholipase A2-mediated surfactant dysfunction[J]. American Journal of Physiology-Lung Cellular and Molecular Physiology, 2005, 288(4): L618-L624 DOI:10.1152/ajplung.00274.2004. [135] HARVAT EM, ZHANG YM, TRAN CV, ZHANG ZG, FRANK MW, ROCK CO, SAIER MH JR. Lysophospholipid flipping across the Escherichia coli inner membrane catalyzed by a transporter (LplT) belonging to the major facilitator superfamily[J]. Journal of Biological Chemistry, 2005, 280(12): 12028-12034 DOI:10.1074/jbc.M414368200. [136] PHANPHAK S, GEORGIADES P, LI RH, KING J, ROBERTS IS, WAIGH TA. Super-resolution fluorescence microscopy study of the production of K1 capsules by Escherichia coli: evidence for the differential distribution of the capsule at the poles and the equator of the cell[J]. Langmuir, 2019, 35(16): 5635-5646 DOI:10.1021/acs.langmuir.8b04122. [137] TEWARI SG, SWIFT RP, REIFMAN J, PRIGGE ST, WALLQVIST A. Metabolic alterations in the erythrocyte during blood-stage development of the malaria parasite[J]. Malaria Journal, 2020, 19(1): 1-18 DOI:10.1186/s12936-019-3075-5. [138] FAHY E, SUD M, COTTER D, SUBRAMANIAM S. LIPID MAPS online tools for lipid research[J]. Nucleic Acids Research, 2007, 35(suppl_2): W606-W612. [139] BARNES MJ, LI CM, XU Y, AN JP, HUANG Y, CYSTER JG. The lysophosphatidylserine receptor GPR174 constrains regulatory T cell development and function[J]. The Journal of Experimental Medicine, 2015, 212(7): 1011-1020 DOI:10.1084/jem.20141827. [140] SHANBHAG K, MHETRE A, KHANDELWAL N, KAMAT SS. The lysophosphatidylserines-an emerging class of signalling lysophospholipids[J]. The Journal of Membrane Biology, 2020, 253(5): 381-397 DOI:10.1007/s00232-020-00133-2. [141] RETRA K, de WALICK S, SCHMITZ M, YAZDANBAKHSH M, TIELENS AGM, BROUWERS JFHM, van HELLEMOND JJ. The tegumental surface membranes of Schistosoma mansoni are enriched in parasite-specific phospholipid species[J]. International Journal for Parasitology, 2015, 45(9/10): 629-636. [142] CHAKRABARTI A, MEMBREZ M, MORIN- RIVRON D, SIDDHARTH J, CHOU CJ, HENRY H, BRUCE S, METAIRON S, RAYMOND F, BETRISEY B, LOYER C, PARKINSON SJ, MASOODI M. Transcriptomics-driven lipidomics (TDL) identifies the microbiome-regulated targets of ileal lipid metabolism[J]. Npj Systems Biology and Applications, 2017, 3: 33 DOI:10.1038/s41540-017-0033-0. [143] OTAKE-KASAMOTO Y, KAYAMA H, KISHIKAWA T, SHINZAKI S, TASHIRO T, AMANO T, TANI M, YOSHIHARA T, LI B, TANI H, LIU L, HAYASHI A, OKUZAKI D, MOTOOKA D, NAKAMURA S, OKADA Y, IIJIMA H, TAKEDA K, TAKEHARA T. Lysophosphatidylserines derived from microbiota in Crohn's disease elicit pathological Th1 response[J]. The Journal of Experimental Medicine, 2022, 219(7): e20211291 DOI:10.1084/jem.20211291. [144] BONDARENKO A, WALDECK-WEIERMAIR M, NAGHDI S, POTESER M, MALLI R, GRAIER WF. GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells[J]. British Journal of Pharmacology, 2010, 161(2): 308-320 DOI:10.1111/j.1476-5381.2010.00744.x. [145] SANDOVAL-CALDERÓN M, GUAN ZQ, SOHLENKAMP C. Knowns and unknowns of membrane lipid synthesis in streptomycetes[J]. Biochimie, 2017, 141: 21-29 DOI:10.1016/j.biochi.2017.05.008. [146] PIÑEIRO R, FALASCA M. Lysophosphatidylinositol signalling: new wine from an old bottle[J]. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids, 2012, 1821(4): 694-705. [147] WHEELER MB, SEIDEL GE JR. Capacitation of bovine spermatozoa by lysophospholipids and trypsin[J]. Gamete Research, 1989, 22(2): 193-204 DOI:10.1002/mrd.1120220207. [148] LI L, SOLVI C, ZHANG F, QI ZY, CHITTKA L, ZHAO W. Gut microbiome drives individual memory variation in bumblebees[J]. Nature Communications, 2021, 12: 6588 DOI:10.1038/s41467-021-26833-4. [149] POMORSKI T, MEYER TF, NAUMANN M. Helicobacter pylori-induced prostaglandin E2 synthesis involves activation of cytosolic phospholipase A2 in epithelial cells[J]. Journal of Biological Chemistry, 2001, 276(1): 804-810 DOI:10.1074/jbc.M003819200. [150] COLLINS JM, WALKER DI, JONES DP, TUKVADZE N, LIU KH, TRAN VT, UPPAL K, FREDIANI JK, EASLEY KA, SHENVI N, KHADKA M, ORTLUND EA, KEMPKER RR, BLUMBERG HM, ZIEGLER TR. High-resolution plasma metabolomics analysis to detect Mycobacterium tuberculosis- associated metabolites that distinguish active pulmonary tuberculosis in humans[J]. PLoS One, 2018, 13(10): e0205398 DOI:10.1371/journal.pone.0205398. [151] LI X, WANG L, FANG P, SUN Y, JIANG X, WANG H, YANG XF. Lysophospholipids induce innate immune transdifferentiation of endothelial cells, resulting in prolonged endothelial activation[J]. Journal of Biological Chemistry, 2018, 293(28): 11033-11045 DOI:10.1074/jbc.RA118.002752. [152] ALHOUAYEK M, MASQUELIER J, MUCCIOLI GG. Lysophosphatidylinositols, from cell membrane constituents to GPR55 ligands[J]. Trends in Pharmacological Sciences, 2018, 39(6): 586-604 DOI:10.1016/j.tips.2018.02.011. [153] XU KM, SHAO Y, SAAOUD F, GILLESPIE A, DRUMMER C IV, LIU L, LU YF, SUN Y, XI H, TÜKEL Ç, PRATICO D, QIN XB, SUN JX, CHOI ET, JIANG XH, WANG H, YANG XF. Novel knowledge-based transcriptomic profiling of lipid lysophosphatidylinositol-induced endothelial cell activation[J]. Frontiers in Cardiovascular Medicine, 2021, 8: 773473 DOI:10.3389/fcvm.2021.773473. [154] OKA S, NAKAJIMA K, YAMASHITA A, KISHIMOTO S, SUGIURA T. Identification of GPR55 as a lysophosphatidylinositol receptor[J]. Biochemical and Biophysical Research Communications, 2007, 362(4): 928-934 DOI:10.1016/j.bbrc.2007.08.078. [155] JANG KB, PURVIS JM, KIM SW. Supplemental effects of dietary lysophospholipids in lactation diets on sow performance, milk composition, gut health, and gut-associated microbiome of offspring[J]. Journal of Animal Science, 2020, 98(8): skaa227 DOI:10.1093/jas/skaa227. [156] LEE C, MORRIS DL, COPELIN JE, HETTICK JM, KWON IH. Effects of lysophospholipids on short-term production, nitrogen utilization, and rumen fermentation and bacterial population in lactating dairy cows[J]. Journal of Dairy Science, 2019, 102(4): 3110-3120 DOI:10.3168/jds.2018-15777. [157] PRIDE AC, HERRERA CM, GUAN ZQ, GILES DK, STEPHEN TRENT M. The outer surface lipoprotein VolA mediates utilization of exogenous lipids by Vibrio cholerae[J]. mBio, 2013, 4(3): e00305.